All Updates

BUFFALO, NY – November 8, 2023 – Earlier today, cancer survivors gathered at Buffalo’s City Hall alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of

The Senate confirmed Dr. Monica M. Bertagnolli, MD, as the new director of the National Institutes of Health (NIH) today.

WASHINGTON, DC – November 2, 2023 – The Centers for Medicare and Medicaid Services (CMS) released their final rule today for the 2024 Medicare Physician Fee Schedule. The rule finalizes a new reimbursement code for patient navigation services focused on patients with serious illnesses like cancer. “This ruling is a

New data from the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention’s (CDC) National Youth Tobacco Survey (NYTS) found that more than 6.21 million youth reported ever using tobacco products and 2.8 million report current use (past 30 days) of any tobacco product in 2023.

A new national poll reveals that patients are counting on lawmakers to solve the medical debt crisis. U.S. adults say it is past time for federal and state policymakers to act.

A coalition of the country’s leading public health advocacy organizations filed a friend-of-the-court brief in Texas v. Mayorkas in the United States District Court for the Southern District of Texas to urge the court to uphold the Biden administration’s 2022 “public charge” policy. Amici include American Cancer Society; American Cancer Society Cancer Action Network (ACS CAN); American Lung Association; CancerCare; Epilepsy Foundation; Hemophilia Federation of America; Leukemia & Lymphoma Society; Muscular Dystrophy Association; National Multiple Sclerosis Society; National Patient Advocate Foundation; and Susan G. Komen.

The nation’s drug shortage crisis continues to affect cancer patients and survivors with 1 in every 10 (10%) reporting impacts to care, a majority of whom have had difficulties finding substitute medications (68%) and cited treatment delays (45%). The data is part of a new survey by the American Cancer Society Cancer Action Network (ACS CAN).

New findings led by researchers at the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) show that regional trial eligibility screening holds the promise of substantially increasing the number of patients who are found eligible to enroll in cancer clinical trials.